Aesthetic Injectables – Market Insights – Asia Pacific
Although the COVID-19 pandemic significantly impacted the Asia Pacific aesthetic injectable market in the short term, the market will grow rapidly through 2031. The market continues to see recovery following the negative impact of the COVID-19 pandemic. An expanding patient pool—namely emerging patient groups, such as men and younger people—will fuel procedure volumes over the forecast period. New advancements and differentiated products from competitors in the market will also support continued demand for aesthetic injectables.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables (including BTX and dermal fillers) in the Asia Pacific region from 2019 through 2031.
The COVID-19 pandemic has had both short- and long-term impacts on the aesthetic injectable market.
What impact has the COVID-19 pandemic had on the Asia Pacific aesthetic injectable market?
What new trends have emerged as a result of the pandemic?
At what pace is the market recovering in the countries covered?
The aesthetic injectable market and competitive dynamics vary across the Asia Pacific countries covered.
How does growth vary in the different countries and market segments covered?
In which markets have domestic competitors achieved the most success, and why?
How are companies catering to country-specific trends to remain competitive?
Strategic acquisitions and partnerships help manufacturers expand their product portfolios and customer bases.
What are the notable acquisitions and partnerships that have occurred in this market?
What competitive advantages have these transactions provided to the companies involved?
New advancements in treatments and products entering the Asia Pacific market will support sales growth.
What are recent new products that have entered the Asia Pacific region, and which ones are expected going forward?
How do novel products and treatments compare to existing ones in the market?
What are the factors that make a product successful in the aesthetic injectable market in the Asia Pacific market?
Table of contents
- Aesthetic Injectables - Market Insights - Asia Pacific
- Abstract
- Executive Summary
- COVID-19 Updates
- Market Highlights
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Aesthetic Injectable Market Landscape, Asia Pacific (USD), 2020 and 2031
- Competitive Highlights
- Aesthetic Injectable Revenue Market Share Rankings, by Product Type, Asia Pacific, 2021
- Competitive Insights
- Companies Mentioned
- Market Developments
- Recent Events in the Aesthetic Injectable Market, Asia Pacific
- Key Clinical Trials in the Aesthetic Injectable Market, Asia Pacific
- Emerging Products for the Aesthetic Injectable Market, Asia Pacific
- Geographies Covered
- Geographies Covered, Asia Pacific
- Average Currency Exchange Rates
- Procedures and Products Covered
- Aesthetic Injectables Procedures and Products Covered, Asia Pacific
- COVID-19 Updates
- Key Report Updates
- COVID-19 Analysis
- Market Impact
- COVID-19 Impact Assessment Summary, Aesthetic Injectable Market, Asia Pacific
- Major Market Forecast Changes and Assumptions
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132031 (Excluding COVID-19 Impact)
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132031 (Including COVID-19 Impact)
- Competitive Impact
- COVID-19 Competitive Factors and Strategies, Aesthetic Injectables Market, Asia Pacific
- COVID-19 Financial Impact and Competitor Insights
- Market Impact
- Aesthetic Injectable Market
- Market Highlights
- Key Content Updates
- Asia Pacific Aesthetic Injectable Market Drivers
- Asia Pacific Aesthetic Injectable Market Limiters
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Aesthetic Injectable Market, by Country, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Market Forecast Data
- Aesthetic Injectable Procedures, by Product Type, Asia Pacific, 2019u20132031
- Aesthetic Injectable Procedures, by Country, Asia Pacific, 2019u20132031
- Aesthetic Injectable Market, by Product Type, Asia Pacific (USD), 2019u20132031
- Aesthetic Injectable Market Growth, by Product Type, Asia Pacific, 2020u20132031
- Aesthetic Injectable Market, by Country, Asia Pacific (USD), 2019u20132031
- Aesthetic Injectable Market Growth, by Country, Asia Pacific, 2020u20132031
- Market Shares
- Aesthetic Injectable Revenue Market Shares, Asia Pacific, 2021
- Aesthetic Injectable Revenue Market Shares, by Product Type, Asia Pacific, 2021
- Competitive Insights
- Allergan (an AbbVie company) Competitive Insights
- Galderma Competitive Insights
- Competitive Insights for Other Key Competitors
- Market Developments
- Recent Events in the Aesthetic Injectable Market, Asia Pacific
- Key Clinical Trials in the Aesthetic Injectable Market, Asia Pacific
- Emerging Products for the Aesthetic Injectable Market, Asia Pacific
- Market Highlights
- Botulinum Toxin Market
- Market Highlights
- Key Content Updates
- Asia Pacific Botulinum Toxin Market Drivers
- Asia Pacific Botulinum Toxin Market Limiters
- BTX Market, by Country, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Volume of BTX Product per Procedure, by Product Type
- Market Forecast Data
- BTX Procedures, by Country, Asia Pacific, 2019u20132031
- BTX Market, by Country, Asia Pacific (USD), 2019u20132031
- BTX Market Growth, by Country, Asia Pacific, 2020u20132031
- Market Shares
- BTX Revenue Market Shares, Asia Pacific, 2021
- BTX Revenue Market Shares, Asia Pacific, 2021
- Competitive Insights
- Market Highlights
- Dermal Filler Market
- Market Highlights
- Key Content Updates
- Asia Pacific Dermal Filler Market Drivers
- Asia Pacific Dermal Filler Market Limiters
- Dermal Filler Market, by Material, Asia Pacific (USD), 2019u20132031
- Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132031
- Market Definitions
- Volume of Dermal Filler Product per Procedure, by Product
- Market Forecast Data
- Dermal Filler Procedures, by Material, Asia Pacific, 2019u20132031
- Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132031
- Dermal Filler Market, by Material, Asia Pacific (USD), 2019u20132031
- Dermal Filler Market Growth, by Material, Asia Pacific (USD), 2020u20132031
- Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132031
- Dermal Filler Market Growth, by Country, Asia Pacific (USD), 2020u20132031
- HA Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132031
- HA Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132031
- HA Dermal Filler Market Growth, by Country, Asia Pacific, 2020u20132031
- Non-HA Dermal Filler Procedures, by Country, Asia Pacific, 2019u20132031
- Non-HA Dermal Filler Market, by Country, Asia Pacific (USD), 2019u20132031
- Non-HA Dermal Filler Market Growth, by Country, Asia Pacific, 2020u20132031
- Market Shares
- Dermal Filler Revenue Market Shares, Asia Pacific, 2021
- Dermal Filler Revenue Market Shares, Asia Pacific, 2021
- Competitive Insights
- Market Highlights
- Appendix
- Abbreviations
- Bibliography
- Abbreviations
Parth Gandhi is a Research Associate within the Orthopaedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in the aesthetics market. Parth holds a master’s degree in Pharmacy from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka.